Cargando…

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells

BACKGROUND: Galectin-3 (Gal3) plays diverse roles in cancer initiation, progression, and drug resistance depending on tumor type characteristics that are also associated with cancer stem cells (CSCs). Recurrence of breast carcinomas may be attributed to the presence of breast CSCs (BCSCs). BCSCs exi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilmer, Matthias, Mazurek, Nachman, Gilcrease, Michael Z., Byrd, James C., Woodward, Wendy A., Buchholz, Thomas A., Acklin, Kim, Ramirez, Karen, Hafley, Margarete, Alt, Eckhard, Vykoukal, Jody, Bresalier, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043623/ https://www.ncbi.nlm.nih.gov/pubmed/27687248 http://dx.doi.org/10.1186/s13058-016-0757-6

Ejemplares similares

Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics
por: Ilmer, Matthias, et al.
Publicado: (2016)

Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling
por: Song, Shumei, et al.
Publicado: (2012)

Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells
por: Rutering, Jennifer, et al.
Publicado: (2015)

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells
por: Recio-Boiles, Alejandro, et al.
Publicado: (2016)

Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer
por: Gilcrease, Michael Z, et al.
Publicado: (2009)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US
por: Sosa, Alan, et al.
Publicado: (2022)

Mucin 21 confers resistance to apoptosis in an O-glycosylation-dependent manner
por: Tian, Yuan, et al.
Publicado: (2022)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014)

Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer
por: Funkhouser, Avery, et al.
Publicado: (2023)

The sentinel node in breast cancer
por: Collins, Conor D.
Publicado: (2008)

Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53
por: Campion, Carole G., et al.
Publicado: (2013)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015)

Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
por: Blair, Bailey B., et al.
Publicado: (2021)

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
por: Van Wyhe, Renae D., et al.
Publicado: (2018)

Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
por: Yasinska, Inna M., et al.
Publicado: (2019)

Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer
por: Pereira, Jonathas Xavier, et al.
Publicado: (2019)

ASO Author Reflections: Non-radioactive Sentinel Node Localization with Superparamagnetic Iron Oxide in Clinically Node-Negative Breast Cancer Patients: A Possibility for Improvement of the Care Pathway
por: Karsten, Maria Margarete, et al.
Publicado: (2020)

Unmodified autologous stem cells at point of care for chronic myocardial infarction
por: Haenel, Alexander, et al.
Publicado: (2019)

Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications
por: Kato, Taketo, et al.
Publicado: (2021)

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer
por: Thaker, Nikhil G, et al.
Publicado: (2015)

Lymphangiogenesis and lymph node metastasis in breast cancer
por: Cunnick, Giles H, et al.
Publicado: (2008)

Ratios of involved nodes in early breast cancer
por: Vinh-Hung, Vincent, et al.
Publicado: (2004)

Sentinel lymph node biopsies in breast cancer
por: Hess, A, et al.
Publicado: (2001)

Sentinel lymph node biopsy in breast cancer
por: Alsaif, Abdulaziz A.
Publicado: (2015)

Sentinel Lymph Node Biopsy in Breast Cancer
por: Mysorekar, Vijaya V.
Publicado: (2010)

Techniques for sentinel node detection in breast cancer
por: Lee, Joseph C., et al.
Publicado: (2020)

Axillary surgery in node-positive breast cancer()
por: Maggi, Nadia, et al.
Publicado: (2021)

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
por: Grosset, Andrée-Anne, et al.
Publicado: (2014)

Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Effect of statins on breast cancer recurrence and mortality: a review
por: Van Wyhe, Renae D, et al.
Publicado: (2017)

Patients with breast cancer may be at higher risk of colorectal neoplasia
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010)

Galectins and Ovarian Cancer
por: Shimada, Chisa, et al.
Publicado: (2020)

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
por: Skinner, Heath D, et al.
Publicado: (2013)

Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy
por: Kato, Taketo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bj1r96t8ld5ghcvdlheq9k9vru